Vimarsana
Biggest News Aggregation in the World

Page 6 - Biocon Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Biologic Today - Breaking & Trending Today

Trade setup for Thursday: Top 15 things to know before the opening bell - Vimarsana News

Trade setup for Thursday: Top 15 things to know before the opening bell

Based on the OI percentage, 55 stocks were on the short-covering list. These included MCX India, IDFC First Bank, Indraprastha Gas, HDFC AMC, and Indiabulls Housing Finance.

Biocon shares rise after launch of inflammatory disease injection in US - Vimarsana News

Biocon shares rise after launch of inflammatory disease injection in US

HULIO is citrate-free and is made without natural rubber latex to help reduce hypersensitivity reactions.

Biocon Biologics' New mAbs Facility Receives EU GMP Certification for bBevacizumab - Vimarsana News

Biocon Biologics' New mAbs Facility Receives EU GMP Certification for bBevacizumab

Biocon Biologics' integrated, multi-product, monoclonal antibodies Drug Substance manufacturing facility at Biocon Park, Bengaluru, has received a Certificate of GMP Compliance.

Serum Institute to double its investment in Biocon unit to $300 million - Vimarsana News

Serum Institute to double its investment in Biocon unit to $300 million

Serum Institute Life Sciences will now double its investment in Biocon Biologics from $150 million that was announced earlier in 2021 to $300 million.

Biocon-Serum deal: Serum to double investment in Biocon's unit to $300 million - Vimarsana News

Biocon-Serum deal: Serum to double investment in Biocon's unit to $300 million

Serum Life Sciences would make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma Limited.